Zimmer Biomet Holdings Inc. said in a securities filing Monday “it is probable that Biomet will incur additional liabilities related to” DOJ and SEC investigations of FCPA violations that occurred after Biomet’s FCPA settlement in 2012 and during its deferred prosecution agreement.
Search Results for: label/Biomet
Orthopedic device maker Biomet Inc. said in an SEC filing that the DOJ has extended for another year its 2012 deferred prosecution agreement that was part of a 2012 FCPA enforcement action.
Orthopedic device maker Zimmer Biomet Holdings Inc. said in a securities filing Friday the DOJ and SEC are still investigating possible FCPA violations in Brazil and Mexico.
Medical device maker Zimmer Biomet Holdings Inc. agreed Thursday to pay $30.5 million to resolve DOJ and SEC investigations into the company’s “repeat” violations of the Foreign Corrupt Practices Act.
Orthopedic device maker Biomet Inc. said Thursday it was subpoenaed by the SEC for an investigation of possible violations of the terms of an FCPA settlement the company reached two years ago.
The Securities and Exchange Commission is investigating possible violations of the U.S. Foreign Corrupt Practices Act by Biomet Inc., Stryker Corp., Zimmer Holdings Inc., Smith & Nephew plc and Medtronic Inc. They’ve all made announcements about the SEC’s action and deny any violations. The companies make replacement implants for knees, hips and the spine and […]